Risk reduction through skeletal scintigraphy as a screening tool in suspected scaphoid fracture: a literature review

Por Chakravarty, D, Sloan, J, Brenchley, J
Publicado em 2002

Clinical and molecular characterization of patients with cancer of unknown primary in the modern era

Por Varghese, A M, Arora, A, Capanu, M, Camacho, N, Won, H H, Zehir, A, Gao, J, Chakravarty, D, Schultz, N, Klimstra, D S, Ladanyi, M, Hyman, D M, Solit, D B, Berger, M F, Saltz, L B
Publicado no Ann Oncol (2017)

A framework to rank genomic alterations as targets for cancer precision medicine: the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT)

Por Mateo, J, Chakravarty, D, Dienstmann, R, Jezdic, S, Gonzalez-Perez, A, Lopez-Bigas, N, Ng, C K Y, Bedard, P L, Tortora, G, Douillard, J -Y, Van Allen, E M, Schultz, N, Swanton, C, André, F, Pusztai, L
Publicado no Ann Oncol (2018)

Oncologist use and perception of large panel next-generation tumor sequencing

Por Schram, A. M., Reales, D., Galle, J., Cambria, R., Durany, R., Feldman, D., Sherman, E., Rosenberg, J., D’Andrea, G., Baxi, S., Janjigian, Y., Tap, W., Dickler, M., Baselga, J., Taylor, B. S., Chakravarty, D., Gao, J., Schultz, N., Solit, D. B., Berger, M. F., Hyman, D. M.
Publicado no Ann Oncol (2017)